APA (7th ed.) Citation

Fernández-Cancio, M., Audí, L., Camats, N., Flück, C. E., Zalewski, A., Pandey, A. V., . . . Torán, N. (2018). Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency. Pharmaceuticals (14248247), 11(2), 37. https://doi.org/10.3390/ph11020037

Chicago Style (17th ed.) Citation

Fernández-Cancio, Mónica, et al. "Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency." Pharmaceuticals (14248247) 11, no. 2 (2018): 37. https://doi.org/10.3390/ph11020037.

MLA (9th ed.) Citation

Fernández-Cancio, Mónica, et al. "Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency." Pharmaceuticals (14248247), vol. 11, no. 2, 2018, p. 37, https://doi.org/10.3390/ph11020037.